Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Organogenesis ORG -- Ignore unavailable to you. Want to Upgrade?

To: jelrod3 who wrote (1213)	3/6/2000 10:54:00 AM
From: Bruce Cullen	Read Replies (2) \| Respond to of 1223

OK good points but... ORG has news that you do not expect, remember this company is now run by a fellow from Glaxo, he is no slow-head, he knows this sector and can make moves as he sleeps. If you think that the Este Lauder pact was a non event just keep watching the options,options are in control of smart money. Smart money says stand back at this point, ORG was not written up by "The Boston Globe" and "Business Week" for no reason. ORG is breaking sales records every month, this will continue, once ORG gets the approval for reimbursements the shorts are all going to cover. Yes new shorts will enter and at some point they will continue to loose, the biotech sector is so hot it's just can't be ignored at this point. The biotech sector is just starting, it may correct, but only a healthy correction... then we start the ball rolling once again. Bruce Cullen sherwoodcoastsgroup.com